Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tree of Life Medical is a specialized medical device company focused on the development of innovative transcatheter solutions for structural heart diseases. The company primarily targets the treatment of mitral and tricuspid valve diseases through its proprietary transcatheter valve replacement and repair platforms. Its lead programs include advanced transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve replacement (TTVR) systems, which are designed to offer minimally invasive alternatives to traditional open-heart surgery. Headquartered in Wuxi, China, the firm integrates research, development, and large-scale manufacturing capabilities to address the growing global burden of valvular heart disease. Tree of Life Medical is backed by prominent venture capital firms and collaborates closely with leading clinical institutions to advance its pipeline through rigorous clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Tree of Life Medical Technology.